Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2992790004;90005;90006 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
N2AB2828685081;85082;85083 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
N2A2735982300;82301;82302 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
N2B2086262809;62810;62811 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
Novex-12098763184;63185;63186 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
Novex-22105463385;63386;63387 chr2:178553121;178553120;178553119chr2:179417848;179417847;179417846
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGT
  • RefSeq wild type template codon: TCA
  • Domain: Ig-147
  • Domain position: 86
  • Structural Position: 173
  • Q(SASA): 0.2637
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/N rs1462504715 -0.535 None N 0.183 0.091 0.0611884634855 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 5.58E-05 None 0 None 0 0 0
S/N rs1462504715 -0.535 None N 0.183 0.091 0.0611884634855 gnomAD-4.0.0 3.42566E-06 None None None None N None 0 0 None 0 2.52232E-05 None 0 0 2.702E-06 1.16055E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0911 likely_benign 0.0931 benign -0.95 Destabilizing None N 0.177 neutral None None None None N
S/C 0.1172 likely_benign 0.1096 benign -0.68 Destabilizing 0.78 D 0.566 neutral N 0.491901436 None None N
S/D 0.5091 ambiguous 0.4138 ambiguous -0.016 Destabilizing 0.081 N 0.523 neutral None None None None N
S/E 0.6837 likely_pathogenic 0.5969 pathogenic -0.042 Destabilizing 0.081 N 0.533 neutral None None None None N
S/F 0.1952 likely_benign 0.2027 benign -1.283 Destabilizing 0.555 D 0.641 neutral None None None None N
S/G 0.1203 likely_benign 0.1154 benign -1.14 Destabilizing 0.027 N 0.504 neutral N 0.497635427 None None N
S/H 0.337 likely_benign 0.2763 benign -1.596 Destabilizing 0.38 N 0.589 neutral None None None None N
S/I 0.1212 likely_benign 0.1177 benign -0.549 Destabilizing 0.188 N 0.621 neutral N 0.466855982 None None N
S/K 0.7568 likely_pathogenic 0.6628 pathogenic -0.583 Destabilizing 0.081 N 0.539 neutral None None None None N
S/L 0.0973 likely_benign 0.1038 benign -0.549 Destabilizing 0.081 N 0.589 neutral None None None None N
S/M 0.1536 likely_benign 0.1479 benign -0.22 Destabilizing 0.555 D 0.575 neutral None None None None N
S/N 0.0957 likely_benign 0.0838 benign -0.447 Destabilizing None N 0.183 neutral N 0.406826243 None None N
S/P 0.4812 ambiguous 0.5469 ambiguous -0.654 Destabilizing 0.555 D 0.591 neutral None None None None N
S/Q 0.5426 ambiguous 0.4636 ambiguous -0.699 Destabilizing 0.38 N 0.584 neutral None None None None N
S/R 0.6817 likely_pathogenic 0.5945 pathogenic -0.462 Destabilizing 0.117 N 0.587 neutral N 0.476936902 None None N
S/T 0.0711 likely_benign 0.0688 benign -0.592 Destabilizing None N 0.165 neutral N 0.425892007 None None N
S/V 0.1516 likely_benign 0.1432 benign -0.654 Destabilizing 0.081 N 0.609 neutral None None None None N
S/W 0.3601 ambiguous 0.353 ambiguous -1.155 Destabilizing 0.935 D 0.655 neutral None None None None N
S/Y 0.192 likely_benign 0.1758 benign -0.917 Destabilizing 0.555 D 0.636 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.